PPAP clinical trials at UCSF
1 research study open to eligible people
Showing trials for
Personalized Perioperative Analgesia Platform (PPAP) for Pediatric Spine Fusion Surgery (sIRB)
open to eligible people ages 10-21
The purpose of this collaborative CTSA application is to develop an innovative perioperative precision analgesia platform (PPAP) to improve analgesia and reduce serious immediate and long-term adverse outcomes of perioperative opioids in children undergoing painful surgery.
San Francisco, California and other locations
Our lead scientists for PPAP research studies include Anshuman Sharma.
Last updated: